DATROWAY Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival as First-Line Therapy for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to…
The 12th World Congress on High-Speed Rail Was Held in Beijing
MODERN RAILWAYS 2025 Held Concurrently BEIJING, July 10, 2025 /PRNewswire/ -- A…
